Cullin E3 Ligases and their rewiring by viral factors

Biomolecules

Volumn 4, Issue 4, 2014, Pages 897-930

  Mahon, Cathal ^a   Krogan, Nevan J ^b   Craik, Charles S ^a   Pick, Elah ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HAIFA   (Israel)

Author keywords

Cullin; Cullin RING ligase; E3; F box protein; Proteasome; Ubiquitin; Virus

Indexed keywords

CULLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; STAT2 PROTEIN; SUMO 1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE E3; DNA VIRUS; PROTEASOME; UBIQUITIN PROTEIN LIGASE; VIRAL PROTEIN;

ANTIGEN RECOGNITION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; NEDDYLATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION; UPREGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PATHOGENICITY; RNA VIRUS; VIRUS; VIRUS INFECTION;

CULLIN PROTEINS; DNA VIRUSES; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA VIRUSES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 84934890539     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom4040897     Document Type: Review

References (153)

1. Ciechanover, A. Intracellular protein degradation: From a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Bioorg. Med. Chem. 2013, 21, 3400-3410.
2. Hershko, A.; Ciechanover, A. The ubiquitin-proteasome pathway. Annu. Rev. Biochem. 1998, 67, 425-479.
3. Deshaies, R.J.; Joazeiro, C.A. Ring domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78, 399-434.
4. Spratt, D.E.; Walden, H.; Shaw, G.S. RBR E3 ubiquitin ligases: New structures, new insights, new questions. Biochem. J. 2014, 458, 421-437.
5. Meng, B.; Lever, A.M. Wrapping up the bad news: HIV assembly and release. Retrovirology 2013, doi:10.1186/1742-4690-10-5.
6. Alcaide-Loridan, C.; Jupin, I. Ubiquitin and plant viruses, let’s play together! Plant. Physiol. 2012, 160, 72-82.
7. Fehr, A.R.; Yu, D. Control the host cell cycle: Viral regulation of the anaphase-promoting complex. J. Virol. 2013, 87, 8818-8825.
8. Rajsbaum, R.; Garcia-Sastre, A. Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol. 2013, 21, 421-429.
9. Choi, A.G.; Wong, J.; Marchant, D.; Luo, H. The ubiquitin-proteasome system in positive-strand RNA virus infection. Rev. Med. Virol. 2013, 23, 85-96.
10. Shackelford, J.; Pagano, J.S. Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem. 2005, 41, 139-156.
11. Shackelford, J.; Pagano, J.S. Role of the ubiquitin system and tumor viruses in AIDS-related cancer. BMC Biochem. 2007, doi:10.1186/1471-2091-8-S1-S8.
12. Wise-Draper, T.M.; Wells, S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front. Biosci. 2008, 13, 1003-1017.
13. Soucy, T.A.; Smith, P.G.; Milhollen, M.A.; Berger, A.J.; Gavin, J.M.; Adhikari, S.; Brownell, J.E.; Burke, K.E.; Cardin, D.P.; Critchley, S., et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 2009, 458, 732-736.
14. Lydeard, J.R.; Schulman, B.A.; Harper, J.W. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 2013, 14, 1050-1061.
15. Lyapina, S.; Cope, G.; Shevchenko, A.; Serino, G.; Tsuge, T.; Zhou, C.; Wolf, D.A.; Wei, N.; Shevchenko, A.; Deshaies, R.J. Promotion of NEDD-cul1 conjugate cleavage by COP9 signalosome. Science 2001, 292, 1382-1385.
16. Schmidt, M.W.; McQuary, P.R.; Wee, S.; Hofmann, K.; Wolf, D.A. F-box-directed CRl complex assembly and regulation by the CSN and CAND1. Mol. Cell 2009, 35, 586-597.
17. Gummlich, L.; Rabien, A.; Jung, K.; Dubiel, W. Deregulation of the COP9 signalosome-Cullin-RING ubiquitin-ligase pathway: Mechanisms and roles in urological cancers. Int. J. Biochem. Cell Biol. 2013, 45, 1327-1337.
18. Malim, M.H.; Bieniasz, P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harbor Perspect. Med. 2012, 2, a006940.
19. Kirchhoff, F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell. Host Microbe 2010, 8, 55-67.
20. Collins, D.R.; Collins, K.L. HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion. PLoS Pathog. 2014, 10, e1003851.
21. Irigoyen, M.L.; Iniesto, E.; Scrima, A.; Bohm, K.; Matsumoto, S.; Lingaraju, G.M.; Faty, M.; Yasuda, T.; Cavadini, S.; Wakasugi, M.; Hanaoka, F., et al. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 2011, 147, 1024-1039.
22. Enchev, R.I.; Scott, D.C.; da Fonseca, P.C.; Schreiber, A.; Monda, J.K.; Schulman, B.A.; Peter, M.; Morris, E.P. Structural basis for a reciprocal regulation between SCF and CSN. Cell Rep. 2012, 2, 616-627
23. Wilton, B.A.; Campbell, S.; van Buuren, N.; Garneau, R.; Furukawa, M.; Xiong, Y.; Barry, M. Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with Cullin-3-based ubiquitin ligases. Virology 2008, 374, 82-99.
24. Wang, Q.; Burles, K.; Couturier, B.; Randall, C.M.; Shisler, J.; Barry, M. Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NFkappab signaling. J. Virol. 2014, 88, 4853-4865
25. Mercer, J.; Snijder, B.; Sacher, R.; Burkard, C.; Bleck, C.K.; Stahlberg, H.; Pelkmans, L.; Helenius, A. RNAi screening reveals proteasome-and Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2012, 2, 1036-1047.
26. Gilson, T.; Cheng, C.Y.; Hur, W.S.; Blanchette, P.; Branton, P.E. Analysis of the Cullin binding sites of the E4orf6 proteins of human adenovirus E3 ubiquitin ligases. J. Virol. 2014, 88, 3885-3897.
27. Cheng, C.Y.; Wimmer, P.; Schreiner, S.; Ketner, G.; Dobner, T.; Branton, P.E.; Blanchette, P. Role of E1b55k in E4orf6/E1b55k E3 ligase complexes formed by different human adenovirus serotypes. J. Virol. 2013, 87 6232-6245.
28. Querido, E.; Blanchette, P.; Yan, Q.; Kamura, T.; Morrison, M.; Boivin, D.; Kaelin, W.G.; Conaway, R.C.; Conaway, J.W.; Branton, P.E. Degradation of p53 by adenovirus E4orf6 and E1b55k proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 2001, 15, 3104-3117.
29. Querido, E.; Morrison, M.R.; Chu-Pham-Dang, H.; Thirlwell, S.W.; Boivin, D.; Branton, P.E. Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1b55k complex. J. Virol. 2001, 75, 699-709.
30. Blackford, A.N.; Patel, R.N.; Forrester, N.A.; Theil, K.; Groitl, P.; Stewart, G.S.; Taylor, A.M.; Morgan, I.M.; Dobner, T.; Grand, R.J., et al. Adenovirus 12 E4orf6 inhibits atr activation by promoting topbp1 degradation. Proc. Natl. Acad. Sci. USA 2010, 107, 12251-12256.
31. Orazio, N.I.; Karlseder, J.; Weitzman, M.D. The adenovirus E1b55k/E4orf6 complex induces degradation of the bloom helicase during infection. J. Virol. 2011, 85, 1887-1892.
32. Dallaire, F.; Blanchette, P.; Groitl, P.; Dobner, T.; Branton, P.E. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1b 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 2009, 83, 5329-5338.
33. Huh, K.; Zhou, X.; Hayakawa, H.; Cho, J.Y.; Libermann, T.A.; Jin, J.; Harper, J.W.; Munger, K. Human papillomavirus type 16 E7 oncoprotein associates with the Cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J. Virol. 2007, 81, 9737-9747.
34. Ashizawa, A.; Higashi, C.; Masuda, K.; Ohga, R.; Taira, T.; Fujimuro, M. The ubiquitin system and kaposi’s sarcoma-associated herpesvirus. Front. Microbiol. 2012, doi:10.3389/fmicb.2012.00066.
35. Ellis, M; Chew, Y.P.; Fallis, L.; Freddersdorf, S.; Boshoff, C.; Weiss, RA.; Lu, X.; Mittnacht, S. Degradation of p27(Kip) Cdk inhibitor triggered by kaposi’s sarcoma virus Cyclin-Cdk6 complex. EMBO J. 1999, 18, 644-653.
36. Liu, J.; Martin, H.; Shamay, M.; Woodard, C.; Tang, Q.Q.; Hayward, S.D. Kaposi’s sarcoma-associated herpesvirus lana protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation. J. Virol. 2007, 81, 4722-4731.
37. Johnston, J.B.; Wang, G.; Barrett, J.W.; Nazarian, S.H.; Colwill, K.; Moran, M.; McFadden, G. Myxoma virus M-t5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell Cullin-1. J. Virol. 2005, 79, 10750-10763.
38. Mitchell, J.K.; Byers, N.M.; Friesen, P.D. Baculovirus F-box protein Lef-7 modifies the host DNA damage response to enhance virus multiplication. J. Virol. 2013, 87, 12592-12599.
39. Rodrigues, L.; Filipe, J.; Seldon, M.P.; Fonseca, L; Anrather, J; Soares, M.P; Simas, J.P. Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J. 2009, 28, 1283-1295.
40. Boggio, R.; Passafaro, A.; Chiocca, S. Targeting SUMO E1 to ubiquitin ligases: A viral strategy to counteract sumoylation. J. Biol. Chem. 2007, 282, 15376-15382.
41. Hartmann, T.; Xu, X.; Kronast, M.; Muehlich, S.; Meyer, K.; Zimmermann, W.; Hurwitz, J.; Pan, Z.Q.; Engelhardt, S.; Sarikas, A. Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen. Proc. Natl. Acad. Sci. USA 2014, 111, 3371-3376.
42. Kasper, J.S.; Kuwabara, H.; Arai, T.; Ali, S.H.; DeCaprio, J.A. Simian virus 40 large T antigen’s association with the Cul7 SCF complex contributes to cellular transformation. J. Virol. 2005, 79, 11685-11692.
43. Van Sant, C.; Hagglund, R.; Lopez, P.; Roizman, B. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the Cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl. Acad. Sci. USA 2001, 98, 8815-8820.
44. Sato, Y.; Kamura, T.; Shirata, N.; Murata, T.; Kudoh, A.; Iwahori, S.; Nakayama, S.; Isomura, H.; Nishiyama, Y.; Tsurumi, T. Degradation of phosphorylated p53 by viral protein-Ecs E3 ligase complex. PLoS Pathog. 2009, doi: 10.1371/journal.ppat.1000530.
45. Gastaldello, S.; Hildebrand, S.; Faridani, O.; Callegari, S.; Palmkvist, M.; di Guglielmo, C.; Masucci, M.G. A deneddylase encoded by epstein-barr virus promotes viral DNA replication by regulating the activity of Cullin-RING ligases. Nat. Cell. Biol. 2010, 12, 351-361.
46. Lozano-Duran, R.; Bejarano, E.R. Geminivirus C2 protein might be the key player for geminiviral co-option of Scf-mediated ubiquitination. Plant. Signal. Behav. 2011, 6, 999-1001.
47. Adeyemi, R.O.; Fuller, M.S.; Pintel, D.J. Efficient parvovirus replication requires CRL4cdt2-targeted depletion of p21 to prevent its inhibitory interaction with PCNA. PLoS Pathog. 2014, 10, e1004055.
48. Aronson, M.N.; Meyer, A.; Györgyey, J.; Katul, L.; Vetten, H.J.; Gronenborn, B.; Timchenko, T. Clink, a nanovirus-encoded protein, binds both pRB and SKP1. J. Virol. 2000, 74, 2967-2972.
49. Graff, J.W.; Ettayebi, K.; Hardy, M.E. Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: A novel mechanism of IFN antagonism. PLoS Pathog. 2009, 5, e1000280.
50. Surjit, M.; Varshney, B.; Lal, S.K. The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of Ikappabalpha in human hepatoma cells. BMC Biochem. 2012, doi:10.1186/1471-2091-13-7.
51. Thiel, H.; Varrelmann, M. Identification of Beet necrotic yellow vein virus P25 pathogenicity factor-interacting sugar beet proteins that represent putative virus targets or components of plant resistance. Mol. Plant. Microbe Interact. 2009, 22, 999-1010.
52. Thiel, H.; Hleibieh, K.; Gilmer, D.; Varrelmann, M. The P25 pathogenicity factor of Beet necrotic yellow vein virus targets the sugar Beet 26S proteasome involved in the induction of a hypersensitive resistance response via interaction with an F-box protein. Mol. Plant. Microbe Interact. 2012, 25, 1058-1072.
53. Chiu, M.H.; Chen, I.H.; Baulcombe, D.C.; Tsai, C.H. The silencing suppressor P25 of potato virus X interacts with argonaute1 and mediates its degradation through the proteasome pathway. Mol. Plant. Pathol. 2010, 11, 641-649.
54. Pazhouhandeh, M.D.M.; Marrocco, K.; Lechner, E.; Berry, B.; Brault, V.; Hemmer, O.; Kretsch, T.; Richards, K.E.; Genschik, P.; Ziegler-Graff, V. F-box-like domain in the polerovirus protein p0 is required for silencing suppressor function. Proc. Natl. Acad. Sci. USA 2006, 103, 1994-1999.
55. Precious, B.; Childs, K.; Fitzpatrick-Swallow, V.; Goodbourn, S.; Randall, R.E. Simian virus 5 V protein acts as an adaptor, linking Ddb1 to Stat2, to facilitate the ubiquitination of Stat1. J. Virol. 2005, 79, 13434-13441.
56. Ulane, C.M.; Horvath, C.M. Paramyxoviruses SV5 and HPIV2 assemble stat protein ubiquitin ligase complexes from cellular components. Virology 2002, 304, 160-166.
57. Elliott, J.; Lynch, O.T.; Suessmuth, Y.; Qian, P.; Boyd, C.R.; Burrows, J.F.; Buick, R.; Stevenson, N.J.; Touzelet, O.; Gadina, M., et al. Respiratory syncytial virus NS1 protein degrades Stat2 by using the elongin-Cullin E3 ligase. J. Virol. 2007, 81, 3428-3436.
58. Le May, N.; Dubaele, S.; Proietti De Santis, L.; Billecocq, A.; Bouloy, M.; Egly, J.M. TFIIH transcription factor, a target for the Rift valley hemorrhagic fever virus. Cell 2004, 116, 541-550.
59. Kainulainen, M.; Habjan, M.; Hubel, P.; Busch, L.; Lau, S.; Colinge, J.; Superti-Furga, G.; Pichlmair, A.; Weber, F. Virulence factor NSS of Rift valley fever virus recruits the F-box protein Fbxo3 to degrade subunit p62 of general transcription factor TFIIH. J. Virol. 2014, 88, 3464-3473.
60. Jager, S.; Kim, D.Y.; Hultquist, J.F.; Shindo, K.; LaRue, R.S.; Kwon, E.; Li, M.; Anderson, B.D.; Yen, L.; Stanley, D., et al. VIF hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 2012, 481, 371-375.
61. Zhang, S.; Zhang, B.; Xu, X.; Wang, L.; Feng, X.; Wang, Q.; Huang, H.; Wu, J.; Li, P.; Wang, J. HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells. Clin. Transl. Oncol. 2014, 16, 293-300.
62. Leupin, O.; Bontron, S.; Schaeffer, C.; Strubin, M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J. Virol. 2005, 79, 4238-4245.
63. Kim, B.; Nguyen, L.A.; Daddacha, W.; Hollenbaugh, J.A. Tight interplay among SAMHD1 protein level, cellular Dntp levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J. Biol. Chem. 2012, 287, 21570-21574.
64. Sitterlin, D.; Bergametti, F.; Transy, C. UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein. Oncogene 2000, 19, 4417-4426.
65. Sitterlin, D.; Bergametti, F.; Tiollais, P.; Tennant, B.C.; Transy, C. Correct binding of viral X protein to Uvddb-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 2000, 19, 4427-4431.
66. Lee, T.H.; Elledge, S.J.; Butel, J.S. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J. Virol. 1995, 69, 1107-1114.
67. Zimmerman, E.S.; Schulman, B.A.; Zheng, N. Structural assembly of Cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 2010, 20, 714-721.
68. Sarikas, A.; Hartmann, T.; Pan, Z.Q. The cullin protein family. Genome Biol. 2011, doi:10.1186/gb-2011-12-4-220.
69. Skaar, J.R.; Pagan, J.K.; Pagano, M. Mechanisms and function of substrate recruitment by F-box proteins. Nat. Rev. Mol. Cell Biol. 2013, 14, 369-381.
70. Skaar, J.R.; D’Angiolella, V.; Pagan, J.K.; Pagano, M. Snapshot: F box proteins II. Cell 2009, doi:10.1016/j.cell.2009.05.040.
71. Xu, L.; Wei, Y.; Reboul, J.; Vaglio, P.; Shin, T.H.; Vidal, M.; Elledge, S.J.; Harper, J.W. BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. Nature 2003, 425, 316-321.
72. Irigoyen, M.L.; Iniesto, E.; Rodriguez, L.; Puga, M.I.; Yanagawa, Y.; Pick, E.; Strickland, E.; Paz-Ares, J.; Wei, N.; de Jaeger, G., et al. Targeted degradation of abscisic acid receptors is mediated by the ubiquitin ligase substrate adaptor DDA1 in arabidopsis. Plant. Cell 2014, 26, 712-728.
73. Pick, E.; Lau, O.S.; Tsuge, T.; Menon, S.; Tong, Y.; Dohmae, N.; Plafker, S.M.; Deng, X.W.; Wei, N. Mammalian DET1 regulates Cul4A activity and forms stable complexes with E2 ubiquitin-conjugating enzymes. Mol. Cell. Biol. 2007, 27, 4708-4719.
74. Thomas, J.C.; Matak-Vinkovic, D.; van Molle, I.; Ciulli, A. Multimeric complexes among ankyrin-repeat and SOCS-box protein 9 (ASB9), elonginBC, and Cullin 5: Insights into the structure and assembly of ECS-type Cullin-RING E3 ubiquitin ligases. Biochemistry 2013, 52, 5236-5246.
75. Ahn, J.; Novince, Z.; Concel, J.; Byeon, C.H.; Makhov, A.M.; Byeon, I.J.; Zhang, P.; Gronenborn, A.M. The Cullin-RING E3 ubiquitin ligase CRL4-DCAF1 complex dimerizes via a short helical region in DCAF1. Biochemistry 2011, 50, 1359-1367.
76. Choo, Y.Y.; Hagen, T. Mechanism of Cullin3 E3 ubiquitin ligase dimerization. PLoS One 2012, 7, e41350.
77. Duda, D.M.; Scott, D.C.; Calabrese, M.F.; Zimmerman, E.S.; Zheng, N.; Schulman, B.A. Structural regulation of Cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 2011, 21, 257-264.
78. Scott, D.C.; Monda, J.K.; Grace, C.R.; Duda, D.M.; Kriwacki, R.W.; Kurz, T.; Schulman, B.A. A dual E3 mechanism for Rub1 ligation to Cdc53. Mol. Cell 2010, 39, 784-796.
79. Kohroki, J.; Nishiyama, T.; Nakamura, T.; Masuho, Y. ASB proteins interact with Cullin5 and RBX2 to form E3 ubiquitin ligase complexes. FEBS Lett. 2005, 579, 6796-6802.
80. Hotton, S.K.; Callis, J. Regulation of Cullin RING ligases. Ann. Rev. Plant Biol. 2008, 59, 467-489.
81. Wee, S.; Geyer, R.K.; Toda, T.; Wolf, D.A. Csn facilitates Cullin-RING ubiquitin ligase function by counteracting autocatalytic adapter instability. Nat. Cell Biol. 2005, 7, 387-391.
82. Schmaler, T.; Dubiel, W. Control of deneddylation by the COP9 signalosome. Sub Cell. Biochem. 2010, 54, 57-68.
83. Ambroggio, X.I.; Rees, D.C.; Deshaies, R.J. Jamm: A metalloprotease-like zinc site in the proteasome and signalosome. PLoS Biol. 2004, 2, e2.
84. Cope, G.A.; Suh, G.S.; Aravind, L.; Schwarz, S.E.; Zipursky, S.L.; Koonin, E.V.; Deshaies, R.J. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of NEDD8 from Cul1. Science 2002, 298, 608-611.
85. Wei, N.; Serino, G.; Deng, X.W. The COP9 signalosome: More than a protease. Trends Biochem. Sci. 2008, 33, 592-600.
86. Peth, A.; Berndt, C.; Henke, W.; Dubiel, W. Downregulation of COP9 signalosome subunits differentially affects the Csn complex and target protein stability. BMC Biochem. 2007, 8, 27.
87. Cope, G.A.; Deshaies, R.J. Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels. BMC Biochem. 2006, 7, 1.
88. Denti, S.; Fernandez-Sanchez, M.E.; Rogge, L.; Bianchi, E. The COP9 signalosome regulates Skp2 levels and proliferation of human cells. J. Biol. Chem. 2006, 281, 32188-32196.
89. Zhou, Z.; Wang, Y.; Cai, G.; He, Q. Neurospora COP9 signalosome integrity plays major roles for hyphal growth, conidial development, and circadian function. PLoS Genet. 2012, 8, e1002712.
90. Pierce, N.W.; Lee, J.E.; Liu, X.; Sweredoski, M.J.; Graham, R.L.; Larimore, E.A.; Rome, M.; Zheng, N.; Clurman, B.E.; Hess, S., et al. Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell 2013, 153, 206-215.
91. Tron, A.E.; Arai, T.; Duda, D.M.; Kuwabara, H.; Olszewski, J.L.; Fujiwara, Y.; Bahamon, B.N.; Signoretti, S.; Schulman, B.A.; DeCaprio, J.A. The glomuvenous malformation protein glomulin binds Rbx1 and regulates Cullin RING ligase-mediated turnover of Fbw7. Mol. Cell 2012, 46, 67-78.
92. Guo, Y.; Dong, L.; Qiu, X.; Wang, Y.; Zhang, B.; Liu, H.; Yu, Y.; Zang, Y.; Yang, M.; Huang, Z. Structural basis for hijacking Cbf-beta and Cul5 E3 ligase complex by HIV-1 Vif. Nature 2014, 505, 229-233.
93. Schwefel, D.; Groom, H.C.; Boucherit, V.C.; Christodoulou, E.; Walker, P.A.; Stoye, J.P.; Bishop, K.N.; Taylor, I.A. Structural basis of lentiviral subversion of a cellular protein degradation pathway. Nature 2014, 505, 234-238.
94. Liu, J.; Nussinov, R. The mechanism of ubiquitination in the Cullin-RING E3 ligase machinery: Conformational control of substrate orientation. PLoS Comput. Biol. 2009, 5, e1000527.
95. Yoshida, Y.; Chiba, T.; Tokunaga, F.; Kawasaki, H.; Iwai, K.; Suzuki, T.; Ito, Y.; Matsuoka, K.; Yoshida, M.; Tanaka, K., et al. E3 ubiquitin ligase that recognizes sugar chains. Nature 2002, 418, 438-442.
96. Jaakkola, P.; Mole, D.R.; Tian, Y.M.; Wilson, M.I.; Gielbert, J.; Gaskell, S.J.; von Kriegsheim, A.; Hebestreit, H.F.; Mukherji, M.; Schofield, C.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001, 292, 468-472.
97. Tan, X.; Calderon-Villalobos, L.I.; Sharon, M.; Zheng, C.; Robinson, C.V.; Estelle, M.; Zheng, N. Mechanism of auxin perception by the Tir1 ubiquitin ligase. Nature 2007, 446, 640-645.
98. Jager, S.; Cimermancic, P.; Gulbahce, N.; Johnson, J.R.; McGovern, K.E.; Clarke, S.C.; Shales, M.; Mercenne, G.; Pache, L.; Li, K., et al. Global landscape of HIV-human protein complexes. Nature 2012, 481, 365-370.
99. Baltimore, D. Expression of animal virus genomes. Bacteriol. Rev. 1971, 35, 235-241.
100. Baker, A.; Rohleder, K.J.; Hanakahi, L.A.; Ketner, G. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 2007, 81, 7034-7040.
101. Schwab, R.A.; Blackford, A.N.; Niedzwiedz, W. ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J. 2010, 29, 806-818.
102. Schreiner, S.; Bürck, C.; Glass, M.; Groitl, P.; Wimmer, P.; Kinkley, S.; Mund, A.; Everett, R.D.; Dobner, T. Control of human adenovirus type 5 gene expression by cellular daxx/atrx chromatin-associated complexes. Nucleic Acid Res. 2013, 41, 3532-3550.
103. Berezutskaya, E.; Bagchi, S. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26S proteasome. J. Biol. Chem. 1997, 272, 30135-30140.
104. Gonzalez, S.L.; Stremlau, M.; He, X.; Basile, J.R.; Munger, K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 2001, 75, 7583-7591.
105. Winter, K.; von Kietzell, K.; Heilbronn, R.; Pozzuto, T.; Fechner, H.; Weger, S. Roles of E4orf6 and va I RNA in adenovirus-mediated stimulation of human parvovirus b19 DNA replication and structural gene expression. J. Virol. 2012, 86, 5099-5109.
106. Angers, S.; Li, T.; Yi, X.; MacCoss, M.J.; Moon, R.T.; Zheng, N. Molecular architecture and assembly of the Ddb1-Cul4A ubiquitin ligase machinery. Nature 2006, 443, 590-593.
107. Precious, B.; Young, D.F.; Andrejeva, L.; Goodbourn, S.; Randall, R.E. In vitro and in vivo specificity of ubiquitination and degradation of Stat1 and Stat2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J. Gen. Virol. 2005, 86, 151-158.
108. Precious, B.L.; Carlos, T.S.; Goodbourn, S.; Randall, R.E. Catalytic turnover of Stat1 allows PIV5 to dismantle the interferon-induced anti-viral state of cells. Virology 2007, 368, 114-121.
109. Albin, J.S.; Anderson, J.S.; Johnson, J.R.; Harjes, E.; Matsuo, H.; Krogan, N.J.; Harris, R.S. Dispersed sites of HIV VIF-dependent polyubiquitination in the DNA deaminase APOBEC3F. J. Mol. Biol. 2013, 425, 1172-1182.
110. Magadan, J.G.; Perez-Victoria, F.J.; Sougrat, R.; Ye, Y.; Strebel, K.; Bonifacino, J.S. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6, e1000869.
111. Dube, M.; Bego, M.G.; Paquay, C.; Cohen, E.A. Modulation of HIV-1-host interaction: Role of the Vpu accessory protein. Retrovirology 2010, 7, 114.
112. Arias, E.E.; Walter, J.C. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat. Cell Biol. 2006, 8, 84-90.
113. Groisman, R.; Polanowska, J.; Kuraoka, I.; Sawada, J.; Saijo, M.; Drapkin, R.; Kisselev, A.F.; Tanaka, K.; Nakatani, Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003, 113, 357-367.
114. Schrofelbauer, B.; Hakata, Y.; Landau, N.R. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. USA 2007, 104, 4130-4135.
115. Benko, Z.; Liang, D.; Agbottah, E.; Hou, J.; Taricani, L.; Young, P.G.; Bukrinsky, M.; Zhao, R.Y. Antagonistic interaction of HIV-1 VPR with Hsf-mediated cellular heat shock response and hsp16 in fission yeast (Schizosaccharomyces pombe). Retrovirology 2007, doi:10.1186/1742-4690-4-16.
116. Cherrier, T.; Suzanne, S.; Redel, L.; Calao, M.; Marban, C.; Samah, B.; Mukerjee, R.; Schwartz, C.; Gras, G.; Sawaya, B.E., et al. P21(Waf1) gene promoter is epigenetically silenced by Ctip2 and SUV39H1. Oncogene 2009, 28, 3380-3389.
117. Maudet, C.; Sourisce, A.; Dragin, L.; Lahouassa, H.; Rain, J.C.; Bouaziz, S.; Ramirez, B.C.; Margottin-Goguet, F. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP. PLoS One 2013, 8, e77320.
118. Wen, X.; Casey Klockow, L.; Nekorchuk, M.; Sharifi, H.J.; de Noronha, C.M. The HIV1 protein Vpr acts to enhance constitutive Dcaf1-dependent UNG2 turnover. PLoS One 2012, 7, e30939.
119. Schrofelbauer, B.; Yu, Q.; Zeitlin, S.G.; Landau, N.R. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and smug Uracil-DNA glycosylases. J. Virol. 2005, 79, 10978-10987.
120. Fregoso, O.I.; Ahn, J.; Wang, C.; Mehrens, J.; Skowronski, J.; Emerman, M. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog. 2013, 9, e1003496.
121. Laguette, N.; Bregnard, C.; Hue, P.; Basbous, J.; Yatim, A.; Larroque, M.; Kirchhoff, F.; Constantinou, A.; Sobhian, B.; Benkirane, M. Premature activation of the Slx4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 2014, 156, 134-145.
122. Laguette, N.; Rahm, N.; Sobhian, B.; Chable-Bessia, C.; Munch, J.; Snoeck, J.; Sauter, D.; Switzer, W.M.; Heneine, W.; Kirchhoff, F., et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 2012, 11, 205-217.
123. Hrecka, K.; Hao, C.; Gierszewska, M.; Swanson, S.K.; Kesik-Brodacka, M.; Srivastava, S.; Florens, L.; Washburn, M.P.; Skowronski, J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474, 658-661.
124. Ryoo, J.; Choi, J.; Oh, C.; Kim, S.; Seo, M.; Kim, S.Y.; Seo, D.; Kim, J.; White, T.E.; Brandariz-Nunez, A., et al. The ribonuclease activity of samhd1 is required for HIV-1 restriction. Nat. Med. 2014, 20, 936-941.
125. Turrini, F.; di Pietro, A.; Vicenzi, E. Lentiviral effector pathways of TRIM proteins. DNA Cell Biol. 2014, 33, 191-197.
126. Bontron, S.; Lin-Marq, N.; Strubin, M. Hepatitis B virus X protein associated with UV-Ddb1 induces cell death in the nucleus and is functionally antagonized by UV-Ddb2. J. Biol. Chem. 2002, 277, 38847-38854.
127. Martin-Lluesma, S.; Schaeffer, C.; Robert, E.I.; van Breugel, P.C.; Leupin, O.; Hantz, O.; Strubin, M. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008, 48, 1467-1476.
128. Kew, M.C. Hepatitis B virus X protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2011, 26, 144-152.
129. Yun, J.W.; Bae, I.H.; Park, Y.H.; Chung, J.H.; Lim, K.M.; Kang, K.S. Expression levels of pituitary tumor transforming 1 and glutathione-S-transferase theta 3 are associated with the individual susceptibility to D-galactosamine-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 2010, 242, 91-99.
130. Zhang, Z.; Torii, N.; Furusaka, A.; Malayaman, N.; Hu, Z.; Liang, T.J. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J. Biol. Chem. 2000, 275, 15157-15165.
131. Jin, Y.; Ma, D.; Dong, J.; Jin, J.; Li, D.; Deng, C.; Wang, T. HC-pro protein of potato virus Y can interact with three arabidopsis 20S proteasome subunits in planta. J. Virol. 2007, 81, 12881-12888.
132. Wang, Q.; Li, C.; Zhang, Q.; Wang, T.; Li, J.; Guan, W.; Yu, J.; Liang, M.; Li, D. Interactions of Sars coronavirus nucleocapsid protein with the host cell proteasome subunit p42. Virol. J. 2010, doi:10.1186/1743-422X-7-99.
133. Li, G.; Elder, R.T.; Dubrovsky, L.; Liang, D.; Pushkarsky, T.; Chiu, K.; Fan, T.; Sire, J.; Bukrinsky, M.; Zhao, R.Y. HIV-1 replication through Hhr23A-mediated interaction of Vpr with 26S proteasome. PLoS One 2010, 5, e11371.
134. Jung, J.; Byeon, I.J.; DeLucia, M.; Koharudin, L.M.; Ahn, J.; Gronenborn, A.M. Binding of HIV-1 Vpr protein to the human homolog of the yeast DNA repair protein Rad23 (Hhr23A) requires its xeroderma pigmentosum complementation group C binding (Xpcb) domain as well as the ubiquitin-associated 2 (Uba2) domain. J. Biol. Chem. 2014, 289, 2577-2588.
135. Dou, Q.P.; Goldfarb, R.H. Bortezomib (millennium pharmaceuticals). IDrugs 2002, 5, 828-834.
136. Gustin, J.K.; Moses, A.V.; Fruh, K.; Douglas, J.L. Viral takeover of the host ubiquitin system. Front. Microbiol. 2011, doi:10.3389/fmicb.2011.00161.
137. Raaben, M.; Grinwis, G.C.; Rottier, P.J.; de Haan, C.A. The proteasome inhibitor velcade enhances rather than reduces disease in mouse hepatitis coronavirus-infected mice. J. Virol. 2010, 84, 7880-7885.
138. Lupfer, C.; Patton, K.M.; Pastey, M.K. Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (velcade, PS-341) results in increased inflammation and mortality. Toxicology 2010, 268, 25-30.
139. Vassilev, L.T.; Vu, B.T.; Graves, B.; Carvajal, D.; Podlaski, F.; Filipovic, Z.; Kong, N.; Kammlott, U.; Lukacs, C.; Klein, C., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004, 303, 844-848.
140. Anderica-Romero, A.C.; Gonzalez-Herrera, I.G.; Santamaria, A.; Pedraza-Chaverri, J. Cullin 3 as a novel target in diverse pathologies. Redox Biol. 2013, 1, 366-372.
141. Zhao, Y.; Sun, Y. Cullin-RING ligases as attractive anti-cancer targets. Curr. Pharm. Design 2013, 19, 3215-3225.
142. Sharma, P.; Nag, A. Cul4A ubiquitin ligase: A promising drug target for cancer and other human diseases. Open Biol. 2014, 4, 130217.
143. Nekorchuk, M.D.; Sharifi, H.J.; Furuya, A.K.; Jellinger, R.; de Noronha, C.M. HIV relies on neddylation for ubiquitin ligase-mediated functions. Retrovirology 2013, 10, 138.
144. Kramer, V.G.; Schader, S.M.; Oliveira, M.; Colby-Germinario, S.P.; Donahue, D.A.; Singhroy, D.N.; Tressler, R.; Sloan, R.D.; Wainberg, M.A. Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load. Antimicrob. Agents Chemother. 2012, 56, 4154-4160.
145. Nathans, R.; Cao, H.; Sharova, N.; Ali, A.; Sharkey, M.; Stranska, R.; Stevenson, M.; Rana, T.M. Small-molecule inhibition of HIV-1 Vif. Nat. Biotechnol. 2008, 26, 1187-1192.
146. Cen, S.; Peng, Z.G.; Li, X.Y.; Li, Z.R.; Ma, J.; Wang, Y.M.; Fan, B.; You, X.F.; Wang, Y.P.; Liu, F., et al. Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. J. Biol. Chem. 2010, 285, 16546-16552.
147. Harper, J.W.; Tan, M.K. Understanding Cullin-RING E3 biology through proteomics-based substrate identification. Mol. Cell. Proteomics 2012, 11, 1541-1550.
148. Emanuele, M.J.; Elia, A.E.; Xu, Q.; Thoma, C.R.; Izhar, L.; Leng, Y.; Guo, A.; Chen, Y.N.; Rush, J.; Hsu, P.W., et al. Global identification of modular Cullin-RING ligase substrates. Cell 2011, 147, 459-474.
149. Mark, K.G.; Simonetta, M.; Maiolica, A.; Seller, C.A.; Toczyski, D.P. Ubiquitin ligase trapping identifies an Scf(Saf1) pathway targeting unprocessed vacuolar/lysosomal proteins. Mol. Cell 2014, 53, 148-161.
150. Salahudeen, A.A.; Thompson, J.W.; Ruiz, J.C.; Ma, H.W.; Kinch, L.N.; Li, Q.; Grishin, N.V.; Bruick, R.K. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 2009, 326, 722-726.
151. Vashisht, A.A.; Zumbrennen, K.B.; Huang, X.; Powers, D.N.; Durazo, A.; Sun, D.; Bhaskaran, N.; Persson, A.; Uhlen, M.; Sangfelt, O., et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 2009, 326, 718-721.
152. Sheehy, A.M.; Gaddis, N.C.; Choi, J.D.; Malim, M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418, 646-650.
153. Khadka, S.; Vangeloff, A.D.; Zhang, C.; Siddavatam, P.; Heaton, N.S.; Wang, L.; Sengupta, R.; Sahasrabudhe, S.; Randall, G.; Gribskov, M., et al. A physical interaction network of dengue virus and human proteins. Mol. Cell. Proteomics 2011, doi: 10.1074/mcp.M111.012187.